With Alzheimer’s disease, DNA mutations occur in brain cells at a much faster rate than normal. Thanks to a recent study from researchers at Brigham Women’s Hospital and Boston Children’s Hospital we may be one step closer to understanding why this hap…
The Dutch Center for Infectious Disease Control (RIVM) released interim results on Tuesday, June 21st, which show that approximately 50% of patients enrolled in a large ongoing study still have one or more symptoms three months after becoming infected …
The course of SARS-CoV-2 infection can vary considerably from person to person. Some experience only mild symptoms, whereas others require hospitalization. New research shows that the presence of autoantibodies against type I interferons can help predi…
In Asia, there are currently four vaccines in late stage clinical trials. These vaccines protect against EV-A71, an enterovirus very similar to EV-D68, the main culprit of Acute Flaccid Myelitis in the US.
With each global health crisis it becomes clear that we need both medical solutions and the public health orientated behavioral and social change programs to implement them.
SARS-CoV-2 has a variety of accessory proteins that help it evade and suppress our immune system. Recent findings suggest that the accessory protein ORF7a helps suppress our immune cells, making it harder for the virus to be detected.